|
Delayed
Nasdaq
22:19:06 01/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 5.100 USD | +3.87% |
|
+2.00% | -65.73% |
| 08-14 | Seres Therapeutics Files $300 Million Mixed Shelf | MT |
| 08-05 | Seres Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +3.87% | +2.00% | +1.39% | -33.25% | -65.73% | -73.87% | -92.98% | -96.11% | -97.49% | 48.81M | |
| -0.25% | -0.92% | +20.22% | +51.97% | +70.34% | +49.47% | +89.45% | +16.27% | - | 68.13B | |
| +1.21% | +0.80% | +22.71% | +23.43% | +23.63% | +46.29% | +85.32% | +211.28% | +6,252.69% | 63.6B | |
| +1.31% | +1.81% | +27.72% | +48.41% | +57.38% | +49.04% | +12.07% | -58.90% | - | 25.57B | |
| -0.95% | -2.46% | +22.74% | +13.97% | -30.57% | -16.83% | +433.75% | +314.83% | +802.46% | 26.6B | |
| -1.27% | -11.95% | +8.86% | +9.51% | +5.48% | -0.20% | -17.52% | -69.80% | - | 25.52B | |
| -6.09% | -11.19% | +23.58% | +56.25% | +209.18% | +224.80% | +351.08% | +1,722.16% | +883.30% | 18.23B | |
| +1.18% | -2.23% | +16.31% | +30.99% | +5.92% | +30.87% | -19.04% | -28.60% | +102.74% | 19.69B | |
| -1.49% | -6.35% | +1.24% | +6.02% | +24.89% | +7.84% | +540.26% | - | - | 15.16B | |
| +2.75% | -1.16% | +1.82% | +11.50% | +27.90% | +50.78% | +146.53% | +186.90% | +393.92% | 13.54B | |
| -0.39% | +5.26% | +11.84% | +12.02% | -7.43% | +23.61% | +191.18% | +544.38% | +4,437.79% | 12.48B | |
| +0.07% | -7.09% | -3.99% | +9.81% | +24.39% | +221.57% | +195.35% | +20.57% | +1,069.69% | 11.64B | |
| -4.73% | -3.06% | -8.83% | -27.48% | -24.20% | -44.99% | +148.62% | +113.06% | - | 10.56B | |
| +4.92% | +7.19% | +9.77% | -8.85% | -18.12% | -39.93% | +778.53% | +96.70% | +115.37% | 10.87B | |
| +1.24% | -6.93% | -5.70% | -2.16% | +13.46% | +45.28% | +100.25% | +118.32% | +586.57% | 9.86B | |
| +0.13% | +0.20% | +1.71% | +138.96% | +82.49% | +174.12% | +390.47% | +260.42% | - | 9.01B | |
| +0.30% | -0.49% | +13.56% | +24.29% | +31.75% | +92.62% | +14.48% | +125.82% | - | 9.04B | |
| -1.07% | -3.72% | +10.28% | +8.91% | +298.23% | +231.30% | +415.36% | -33.18% | - | 8.43B | |
| -1.67% | +6.94% | -2.94% | -3.99% | +10.21% | -19.15% | +116.80% | -21.04% | - | 8.55B | |
| -1.48% | -18.27% | -7.57% | +24.38% | +167.83% | +427.60% | +505.10% | -51.59% | -39.33% | 7.88B | |
| Average | -0.10% | -1.61% | +8.24% | +19.73% | +45.35% | +74.01% | +219.25% | +177.45% | +1,318.88% | 18.72B | |
| Weighted average by Cap. | -0.15% | -2.11% | +14.30% | +27.58% | +44.33% | +60.35% | +178.74% | +183.87% | +2,659.20% |
- Stock Market
- Stocks
- MCRB Stock
- Sector Seres Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
